TORONTO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) and Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) ("Isodiol") are pleased to announce a distribution relationship to distribute Isodiol's "Pot-O-Coffee" branded products in the states of Colorado, Oregon, Washington and Illinois.
Nutritional High and Isodiol have entered into an agreement ("Agreement"), whereby Nutritional High will distribute (or sell packaging to licensed operators in the states with residency requirement) Isodiol Pot-O-Coffee, Pot-O-Tea, and Pot-O-Coco product lines. The Agreement will focus on specific markets in Colorado, Oregon, Washington, California and Illinois, in cooperation with Nutritional High's partner companies. As a part of the Agreement, Nutritional High will complete the final stage of manufacturing by infusing its cannabis into the product (or implement the necessary quality assurance procedures to ensure that its partners do so) and will provide a royalty to Isodiol.
Jim Frazier, CEO of Nutritional High commented: "We are pleased to announce the joint commercialization strategy with Isodiol. We feel this is an opportunity to work with a leading international player in the space that has a track record with developing and commercializing cannabis-based consumer products. This partnership will help us expand our product reach in North America and leverage the infrastructure that we have and continue to build."
“This strategic alliance with Nutritional High will offer our customers greater access to Pot-O-Coffee products via a reputable manufacturer and distributor," said Marcos Agramont, CEO of Isodiol. "With the recent transaction involving our Canadian licensing partner (see news release announced July 20, 2017) Canopy Growth Corporation and Constellation Brands, we feel the infused beverage industry will make significant strides in the near future.”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products and nationally recognized brands in the marijuana-infused products industry, including edibles and oil extracts for nutritional, medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
For updates on the Company's activities and highlights of the Company's press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagram and Google+ or visit www.nutritionalhigh.com.
About Isodiol International Inc.
Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.
For further information, please contact:
David Posner, Chairman of the Board
Nutritional High International Inc.
647-985-6727
Email: dposner@nutritionalhigh.com
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include submission of the relevant documentation within the required timeframe and to the satisfaction of the relevant regulators, completing the acquisition of the applicable real estate and raising sufficient financing to complete the Company's business strategy. There is no certainty that any of these events will occur. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.